2015
DOI: 10.1124/dmd.115.065615
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Kinetic Characterization of Axitinib Metabolism

Abstract: , respectively. Using a CYP3A4-specific inhibitor (Cyp3cide) in liver microsomes expressing CYP3A5, 66% of the axitinib intrinsic clearance was attributable to CYP3A4 and 15% to CYP3A5. Axitinib N-glucuronidation was primarily catalyzed by UDPglucuronosyltransferase (UGT) UGT1A1, which was verified by chemical inhibitors and UGT1A1 null expressers, with lesser contributions from UGTs 1A3, 1A9, and 1A4. The K m and V max values describing the formation of the N-glucuronide in HLM or rUGT1A1 were 2.7 mM or 0.75 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
20
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 32 publications
(20 citation statements)
references
References 34 publications
0
20
0
Order By: Relevance
“…Intestinal permeability was predicted based on in vitro kinetic data generated using untransfected Caco‐2 cells . Metabolism and elimination parameters were calculated by scaling reported intersystem extrapolation factor–adjusted in vitro CYP and uridine 5′‐diphospho‐glucuronosyltransferase data and in vivo data based on the impact of clinical index inhibitors (Figure ). As passive diffusion is the dominant mechanism for axitinib compartmental distribution, transporter kinetics were not incorporated into the model.…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…Intestinal permeability was predicted based on in vitro kinetic data generated using untransfected Caco‐2 cells . Metabolism and elimination parameters were calculated by scaling reported intersystem extrapolation factor–adjusted in vitro CYP and uridine 5′‐diphospho‐glucuronosyltransferase data and in vivo data based on the impact of clinical index inhibitors (Figure ). As passive diffusion is the dominant mechanism for axitinib compartmental distribution, transporter kinetics were not incorporated into the model.…”
Section: Methodsmentioning
confidence: 99%
“…At neutral pH (ie, 7.4) the solubility of axitinib is <1 μM, although evidence suggests that the impact of pH on axitinib absorption is not clinically relevant under normal dosing conditions . Axitinib is primarily cleared by cytochrome P450 (CYP) 3A4, with minor contributions from CYP1A2 and 2C19, and the uridine 5′‐diphospho‐glucuronosyltransferases 1A1, 1A3 and 1A9 . Axitinib has high passive permeability (in vitro P app > 6 × 10 −6 cm/s) and is minimally transported by efflux or uptake transporters .…”
mentioning
confidence: 99%
See 3 more Smart Citations